News
The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded to drugs like Keytruda.
In his ongoing crusade to make America sicker, Health Secretary Robert F. Kennedy Jr. has axed about $500 million in mRNA vaccine research funding.
Sen. Bill Cassidy is facing the consequences of his vote to confirm the anti-vaxxer as Donald Trump's health and human ...
TOKYO -- Japanese biotechnology company PrimRNA will launch clinical trials for a treatment using messenger RNA to repair osteoarthritis of the knee, a condition that afflicts many older adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results